Lindsay A Md Rosenwald Avenue Therapeutics, Inc. (ATXI) insider trading activity

Lindsay A Md Rosenwald is Director of AVENUE THERAPEUTICS, INC.. Currently has a direct ownership of 354,318 shares of ATXI, which is worth approximately $1.21 Million. The most recent transaction as insider was on Sep 08, 2023, when has been sold 348,675 shares (Common Stock) at a price of $0.72 per share, resulting in proceeds of $251,046. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 354K

0% 3M change

n/a 12M change

Total Value Held $1.21 Million

LINDSAY A MD ROSENWALD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Sep 08 2023	BUY Open market or private purchase	$251,046 $0.72 p/Share	348,675 Added 49.6%	354,318 Common Stock

Also insider at

CKPT

Checkpoint Therapeutics, Inc. Healthcare

Director

FBIO

Fortress Biotech, Inc. Healthcare

President, CEO & Chairman

DERM

Journey Medical Corp Healthcare

Director

MBIO

MUSTANG BIO, INC. Healthcare

Director

LAM